Article Details

UniQure's AMT-130 Gets FDA RMAT Designation For Treating Huntington's Disease

Retrieved on: 2024-06-03 12:51:08

Tags for this article:

Click the tags to see associated articles and topics

UniQure's AMT-130 Gets FDA RMAT Designation For Treating Huntington's Disease. View article details on hiswai:

Excerpt

... has granted its investigational gene therapy AMT-130 for treating Huntington's disease a Regenerative Medicine Advanced Therapy or RMAT designation.

Article found on: www.rttnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up